Brief: Innocan Pharma announces presentation at Painweek Conference
20/06/2025 21:04
June 20 (Reuters) - Innocan Pharma Corp INNO.CD: INNOCAN PHARMA ANNOUNCES PRESENTATION OF NARRATIVE REVIEW ON LONG-ACTING SYNTHETIC CANNABIDIOL FOR CHRONIC PAIN AT PAINWEEK CONFERENCE Source text: ID:nPre4p17ja Further company coverage: INNO.CD ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innocan Pharma
See all newsBrief: Innocan Pharma Corp To Offer Up To 3.75 Million Units In IPO - SEC Filing
Brief: Innocan Pharma Announces Promising Results Of LPT-CBD Administered To Gottingen Minipigs
Brief: Innocan Pharma Corp - Liposomal Cbd Injection Technology Patent Allowed In Japan
Brief: Innocan Pharma Corp Now Sees U.S IPO Of 1.1 Million Units - SEC Filing
Brief: Innocan Pharma Announces Details Of Proposed Share Consolidation